ScoreWhy is Jointown Pharmaceutical Group Co., Ltd. ?
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 8.18% and Operating profit at -3.61% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 9.63% signifying low profitability per unit of shareholders funds
2
Poor long term growth as Net Sales has grown by an annual rate of 8.18% and Operating profit at -3.61% over the last 5 years
3
Flat results in Sep 25
- INVENTORY TURNOVER RATIO(HY) Lowest at 6.89 times
- OPERATING PROFIT(Q) Lowest at CNY 908.43 MM
- OPERATING PROFIT MARGIN(Q) Lowest at 2.38 %
4
With ROE of 10.88%, it has a fair valuation with a 0.88 Price to Book Value
- Over the past year, while the stock has generated a return of 4.15%, its profits have risen by 40.4% ; the PEG ratio of the company is 0.9
- At the current price, the company has a high dividend yield of 4.1
5
Underperformed the market in the last 1 year
- The stock has generated a return of 4.15% in the last 1 year, much lower than market (China Shanghai Composite) returns of 22.49%
Real-Time Research ReportHow much should you sell?
- All quantity irrespective of whether you are making profits or losses
(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Retailing)
When to re-enter? - We will constantly monitor the company and review our call based on new data
Is Jointown Pharmaceutical Group Co., Ltd. for you?
Low Risk, Low Return
Absolute
Risk Adjusted
Volatility
Jointown Pharmaceutical Group Co., Ltd.
-9.23%
-0.08
21.65%
China Shanghai Composite
16.78%
1.58
14.20%
Quality
Management Risk
Growth
Capital StructureQuality key factors
Factor
Value
Sales Growth (5y)
7.13%
EBIT Growth (5y)
-2.38%
EBIT to Interest (avg)
3.00
Debt to EBITDA (avg)
5.94
Net Debt to Equity (avg)
0.96
Sales to Capital Employed (avg)
2.19
Tax Ratio
24.12%
Dividend Payout Ratio
44.72%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
7.08%
ROE (avg)
9.63%
ValuationValuation Key Factors 
Factor
Value
P/E Ratio
14
Industry P/E
Price to Book Value
0.82
EV to EBIT
16.76
EV to EBITDA
13.98
EV to Capital Employed
0.92
EV to Sales
0.34
PEG Ratio
NA
Dividend Yield
8.35%
ROCE (Latest)
5.46%
ROE (Latest)
5.98%
TechnicalsTechnical key factors
Indicator
Weekly
Monthly
MACD
Bearish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Mildly Bullish
Dow Theory
No Trend
Mildly Bearish
OBV
Mildly Bullish
No Trend
Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish Turned 
Financial Trend4What is working for the Company
RAW MATERIAL COST(Y)
Fallen by -8.75% (YoY
CASH AND EQV(HY)
Highest at CNY 38,959.98 MM
DEBTORS TURNOVER RATIO(HY)
Highest at 3.66 times
NET SALES(Q)
Highest at CNY 44,782.65 MM
-21What is not working for the Company
NET PROFIT(HY)
At CNY 812.32 MM has Grown at -54.51%
ROCE(HY)
Lowest at 7.02%
INTEREST COVERAGE RATIO(Q)
Lowest at 268.37
DEBT-EQUITY RATIO
(HY)
Highest at 109.48 %
INVENTORY TURNOVER RATIO(HY)
Lowest at 5.76 times
INTEREST(Q)
Highest at CNY 319.03 MM
OPERATING PROFIT(Q)
Lowest at CNY 856.17 MM
OPERATING PROFIT MARGIN(Q)
Lowest at 1.91 %
PRE-TAX PROFIT(Q)
Lowest at CNY 452.59 MM
Here's what is working for Jointown Pharmaceutical Group Co., Ltd.
Net Sales
Highest at CNY 44,782.65 MM
in the last five periodsMOJO Watch
Near term sales trend is positive
Net Sales (CNY MM)
Cash and Eqv
Highest at CNY 38,959.98 MM
in the last six Semi-Annual periodsMOJO Watch
Short Term liquidity is improving
Cash and Cash Equivalents
Debtors Turnover Ratio
Highest at 3.66 times
in the last five Semi-Annual periodsMOJO Watch
Company has been able to sell its Debtors faster
Debtors Turnover Ratio
Raw Material Cost
Fallen by -8.75% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has improved; this may lead to a rise in profit margin
Raw Material Cost as a percentage of Sales
Here's what is not working for Jointown Pharmaceutical Group Co., Ltd.
Net Profit
At CNY 812.32 MM has Grown at -54.51%
Year on Year (YoY)MOJO Watch
Near term Net Profit trend is very negative
Net Profit (CNY MM)
Interest
At CNY 319.03 MM has Grown at 21.5%
period on period (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Interest Coverage Ratio
Lowest at 268.37
in the last five periodsMOJO Watch
The company's ability to manage interest payments is deteriorating
Operating Profit to Interest
Interest
Highest at CNY 319.03 MM
in the last five periods and Increased by 21.5% (QoQ)MOJO Watch
Rising interest cost signifies increased borrowings
Interest Paid (CNY MM)
Operating Profit
Lowest at CNY 856.17 MM
in the last five periodsMOJO Watch
Near term Operating Profit trend is negative
Operating Profit (CNY MM)
Operating Profit Margin
Lowest at 1.91 %
in the last five periodsMOJO Watch
Company's profit margin has deteriorated
Operating Profit to Sales
Pre-Tax Profit
Lowest at CNY 452.59 MM
in the last five periodsMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Pre-Tax Profit
At CNY 452.59 MM has Fallen at -40.56%
over average net sales of the previous four periods of CNY 761.44 MMMOJO Watch
Near term Pre-Tax Profit trend is negative
Pre-Tax Profit (CNY MM)
Debt-Equity Ratio
Highest at 109.48 %
in the last five Semi-Annual periodsMOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed
Debt-Equity Ratio
Inventory Turnover Ratio
Lowest at 5.76 times
in the last five Semi-Annual periodsMOJO Watch
Company's pace of selling inventory has slowed
Inventory Turnover Ratio
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."
